Atlas Trials

A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients

Clinical trial NCT00675545 · COMPLETED

Trial details

NCT number
NCT00675545
Sponsor
National University Hospital, Singapore
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone-Refractory Prostate Cancer
Start date
2007-05-01
Primary completion
2010-05-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.